Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Musculoskeletal Disorders Therapeutics Market 2016-2020 with AbbVie, Johnson & Johnson, Amgen, Pfizer, F. Hoffmann-La Roche & Eli Lilly Dominating - Research and Markets

Research and Markets
Posted on: 21 Sep 16

Research and Markets has announced the addition of the "Global Musculoskeletal Disorders Therapeutics Market 2016-2020" report to their offering.

About Musculoskeletal Disorders

The global musculoskeletal disorder therapeutics market to grow at a CAGR of 4.46% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global musculoskeletal disorder therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used to treat musculoskeletal disorders including osteoarthritis, rheumatoid arthritis, osteoporosis, ankylosing spondylitis, psoriatic arthritis, and fibromyalgia.

Musculoskeletal disorders are the group of pain disorders or injuries that affect the body's joints, muscles, nerves, ligaments, tendons, and structures, all of which support the hands, legs, neck and back. The pain and discomfort vary with the severity of the condition. These disorders have a wide range of causes, but usually occur depending on the age, lifestyle, and occupation of an individual. Symptoms usually range from recurrent pain, stiffness, and swellings. X-rays and other medical imaging procedures may diagnose the condition. The treatment mainly depends on the severity of the condition. Apart from the drugs, physical therapy, and occupational therapy are also used to manage the condition.

Key vendors

  • AbbVie
  • Johnson & Johnson
  • Amgen
  • Pfizer
  • F. Hoffmann-La Roche
  • Eli Lilly

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: Pipeline portfolio

Part 06: Market landscape

Part 07: Market segmentation by disease type

Part 08: Global rheumatoid arthritis drugs market

Part 09: Global osteoarthritis drugs market

Part 10: Global osteoporosis drugs market

Part 11: Global ankylosing spondylitis drugs market

Part 12: Global psoriatic arthritis drugs market

Part 13: Global fibromyalgia drugs market

Part 14: Market segmentation by type of molecule

Part 15: Market segmentation by route of administration

Part 16: Geographical segmentation

Part 17: Market drivers

Part 18: Impact of drivers

Part 19: Market challenges

Part 20: Impact of drivers and challenges

Part 21: Market trends

Part 22: Vendor landscape

Part 23: Key vendor analysis

For more information about this report visit

Related Topics: Musculoskeletal Disorders Drugs

View source version on

Business Wire

Last updated on: 21/09/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.